Cialis vs Vidalista: Is the Generic Tadalafil Identical to the $70 Brand?

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Tadalafil occupies a particular spot in the ED-medication landscape. Sildenafil (the molecule in Viagra and Cenforce) lasts roughly 4 hours and locks the user into a schedule: take it 30–60 minutes before intercourse, perform within the window, repeat. Tadalafil’s pharmacokinetics are fundamentally different. Its 17.5-hour half-life produces an effective window of 24–36 hours after a single dose — long enough that the timing of sexual activity becomes essentially irrelevant within a 1–2 day window. Most men also tolerate it without the food-timing constraints that limit sildenafil.

Tadalafil’s unique kinetics also support a second dosing regimen that sildenafil cannot: daily low-dose tadalafil, 2.5 or 5 mg every day, which keeps plasma levels in the therapeutic range continuously and returns spontaneity entirely. Daily dosing was specifically FDA-approved in 2008 for this purpose.

The choice between branded Cialis and generic Vidalista — both tadalafil, both WHO-GMP-manufactured at the generic end — comes down to economics and supply chain, not pharmacology. This guide compares the two on active ingredient, dose equivalence, bioequivalence, the two distinct dosing regimens, and safety, then explains the price gap and finishes with practical guidance on choosing between them.

TL;DR comparison table

Both pills contain the same molecule: tadalafil

Tadalafil was approved by the US Food and Drug Administration on 21 November 2003 as the active ingredient in Cialis, five years after sildenafil reached market. Lilly’s pivotal trials, including Brock and colleagues’ 1,112-patient program published in the Journal of Urology¹, demonstrated efficacy at 5, 10, and 20 mg doses with successful intercourse attempts in 67–75% of cases on 20 mg versus 32% on placebo. The pyrazinopyridoindoledione core of tadalafil has not changed since.

Lilly’s US patent on tadalafil for erectile dysfunction expired in November 2017, and FDA-approved generic tadalafil products from Teva, Ascend, and Lupin reached US retail pharmacies in 2018. Outside the US, generic tadalafil entered numerous export markets earlier under different patent regimes. Vidalista, manufactured by Centurion Laboratories Pvt Ltd in Vadodara, Gujarat — the same WHO-GMP-certified facility that produces Cenforce sildenafil — is among the most widely distributed generic tadalafil products globally.

Bioequivalence: are they actually the same pill?

Both FDA and WHO bioequivalence standards apply the same criteria²³:

1. Identical active pharmaceutical ingredient (API) at the same labelled dose.
2. The same route of administration (oral tablet).
3. Human pharmacokinetic studies must demonstrate that the rate of absorption (Cmax) and total exposure (AUC) of the generic fall within 80–125% of the reference product, with the 90% confidence interval entirely inside that window.

Both Cialis and Vidalista contain tadalafil at FDA-recognised dose strengths. Generic tadalafil products sold in US retail pharmacies since 2018 are FDA Orange Book AB-rated — therapeutically equivalent to Cialis and substitutable at the pharmacy counter. Vidalista, because it is not marketed in the United States, does not carry an FDA AB rating. However, Centurion’s manufacturing facility is WHO-GMP certified, and the WHO Prequalification scheme applies the same Cmax/AUC bioequivalence criterion as the FDA.

Practically, a 20 mg Cialis tablet and a 20 mg Vidalista tablet release tadalafil into the bloodstream at the same rate, reach the same peak plasma concentration, and clear at the same rate. The mechanism is mechanically identical.

How tadalafil works — and why it lasts 36 hours

Tadalafil, like sildenafil, inhibits phosphodiesterase type 5 (PDE5), the enzyme that breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle of the penile vasculature and the pulmonary arteries. When PDE5 is inhibited, cGMP accumulates, smooth muscle relaxes, blood fills the corpus cavernosum in response to sexual stimulation, and an erection becomes possible.

What separates tadalafil from sildenafil at the molecular level is binding kinetics. Tadalafil dissociates from PDE5 far more slowly than sildenafil does — in pharmacological terms, tadalafil has a much longer residence time on the enzyme. Combined with a slower hepatic clearance pathway (primarily CYP3A4), this produces tadalafil’s distinguishing 17.5-hour plasma half-life, versus sildenafil’s ~4 hours. The practical consequence: a single tadalafil dose maintains therapeutically meaningful PDE5 inhibition for 24–36 hours, while sildenafil’s window is closer to 4–6 hours.

As with sildenafil, tadalafil does not produce an erection on its own. It requires the body’s natural nitric-oxide signal released during sexual arousal. Without that signal, no cGMP accumulates and no erection occurs.

The two dosing regimens (and why this matters)

Tadalafil’s long half-life supports two distinct, well-studied dosing strategies. This is the most consequential pharmacological difference between tadalafil and sildenafil from a practical-use standpoint.

On-demand dosing: 10 or 20 mg, taken 30 minutes before sexual activity

This mirrors the sildenafil pattern. Take a 10 or 20 mg tablet 30 minutes before anticipated sexual activity, and the effective window opens for the next 24–36 hours. Most users start with 10 mg and titrate up to 20 mg only if response is inadequate. The 36-hour window means a single Friday-evening dose remains active across Saturday night without re-dosing — the “weekend pill” nickname comes from this property.

Daily low-dose: 2.5 or 5 mg taken once every 24 hours

Continuous daily 2.5 mg or 5 mg tadalafil — FDA-approved in 2008 specifically for this regimen — maintains steady-state plasma levels that produce therapeutic PDE5 inhibition continuously. The clinical consequence is that sexual activity becomes possible at any time, without any premeditated dose. For users whose sexual encounters are spontaneous (rather than scheduled), the daily regimen restores natural spontaneity entirely. Daily tadalafil is also FDA-approved at 5 mg for benign prostatic hyperplasia (BPH) symptoms — a useful overlap for men in their 50s and 60s with both indications.

Our companion guide Daily Tadalafil 5 mg vs On-Demand 20 mg covers the trade-off between the two regimens in detail — including cost-per-month, side-effect profile differences, and decision factors.

Doses and dose equivalence

Eli Lilly’s branded Cialis is sold in four FDA-approved strengths: 2.5, 5, 10, and 20 mg. The FDA-labelled on-demand maximum is 20 mg, and the daily maximum is 5 mg. Vidalista, produced for the export market, is offered at the same four strengths plus 40, 60, and 80 mg, and in specialty formats (Vidalista CT chewable, Vidalista Black 80). MedsBase carries the full Vidalista range — browse all Vidalista doses here.

Dose equivalence applies per milligram: 20 mg Vidalista is pharmacologically equivalent to 20 mg Cialis. The higher Vidalista strengths (40, 60, 80 mg) are not FDA-approved doses and exceed the labelled 20 mg ceiling. They exist for men who fail to respond to 20 mg under physician supervision, but the side-effect profile worsens roughly linearly with dose, and the response curve plateaus — doubling the dose from 20 to 40 mg does not double the response. If 20 mg tadalafil doesn’t produce a usable erection, switching molecule (back to sildenafil at a different dose, or to vardenafil or avanafil) is generally more productive than dose escalation.

Price comparison: how the $70 pill became the $1 pill

For daily dosing, the cost difference compounds. A 30-day supply of branded 5 mg daily Cialis at US MSRP is roughly $2,000–$2,400 per month. The equivalent Vidalista 5 mg daily on MedsBase is roughly $25–$45 per month — the difference between a $26,000-per-year medication and a $400-per-year one, for identical pharmacology.

Three forces produce the price gap:

• Patent recovery in branded pricing. Lilly recovered its R&D and clinical-trial investment during the 2003–2017 US patent window. The brand price still carries a marketing margin post-patent.
• Manufacturing scale at the API level. Centurion produces tadalafil API in volumes optimised for the global generic export market. WHO-GMP-compliant production under Indian regulatory oversight is dramatically less expensive than US-based pharmaceutical manufacturing.
• No marketing markup. Vidalista carries no DTC television advertising, no sales-rep visits to clinicians, no PBM rebates. The cost difference reflects marketing economics, not a difference in the molecule.

Side effects: identical molecule, identical profile

Tadalafil’s side-effect profile differs from sildenafil’s, but Cialis and Vidalista — both tadalafil — produce the same side effects at the same rates:¹

• Headache (~14%) — vasodilation in cerebral vasculature
• Dyspepsia / reflux (~10%) — smooth-muscle relaxation in the lower oesophageal sphincter
• Back pain or myalgia (~6%) — the most distinctively tadalafil side effect, generally appearing 12–24 hours after dosing; thought to relate to PDE11 cross-inhibition in skeletal muscle
• Nasal congestion (~4%) — vasodilation in nasal mucosa
• Facial flushing (~4%) — less pronounced than with sildenafil
• Limb pain or muscle cramps (~3%)

One pharmacologically distinct point: tadalafil produces less visual disturbance than sildenafil because it does not cross-react with PDE6 in retinal photoreceptors. Conversely, tadalafil produces more back/muscle pain than sildenafil, likely from PDE11 cross-inhibition in skeletal muscle. These differences are intrinsic to the molecule and apply equally to brand and generic.

Rare serious adverse events include priapism (sustained erection longer than 4 hours, requiring urgent urological care) and sudden hearing or vision loss. These are documented at equivalent rates for both branded and generic tadalafil.

Contraindications and drug interactions (same for both)

Manufacturer disclosure: who makes Vidalista?

Vidalista is manufactured by Centurion Laboratories Pvt Ltd, headquartered in Vadodara, Gujarat — the same facility that produces Cenforce sildenafil and a range of other generic ED, cardiovascular, and respiratory products for the global export market. Centurion’s facility holds WHO-GMP certification under the Indian Central Drugs Standard Control Organisation, and ISO 9001:2015 quality-management certification. WHO-GMP covers cleanroom air-handling standards, batch testing protocols, equipment calibration, raw-material traceability, finished-product release assays, and stability monitoring — the same operational standards that govern WHO Prequalified manufacturers supplying global procurement bodies including UNICEF, UNFPA, and the Global Fund.

Vidalista tablets are released only after batch-level HPLC assay confirming tadalafil content within the 95–105% USP specification window and dissolution testing per USP <711>. Certificates of Analysis are available on request through MedsBase customer support — provide your order ID and the batch number from your blister, and the COA for that batch is emailed within one business day.

How to order Vidalista from MedsBase

Vidalista ships from MedsBase worldwide in discreet packaging (plain envelope, no pharmacy branding, no medication name on the exterior). Payment is accepted via crypto (USDT, BTC, ETH via Plisio), credit card via a regulated crypto on-ramp (the statement descriptor is the on-ramp provider name — a regulated card-payment processor — never MedsBase or anything pharmacy-related), or SEPA bank transfer where available. See our credit card payment guide for detail on the on-ramp flow.

Every order is covered by the MedsBase Reshipment Assurance Policy — if your package fails to arrive within 20 business days of dispatch, a replacement ships at no additional cost (excluding the customer-fault scenarios documented in the policy).

Who should choose which?

The choice between branded Cialis and generic Vidalista is mostly economic, with three secondary considerations:

• Occasional users (1–4 pills per month, US-based): Costco cash-pay generic tadalafil at $5–$15/pill is affordable enough that the cost difference doesn’t compound. Branded Cialis makes sense only if a prescriber objects to generic substitution.
• Regular on-demand users (4–8 pills per month) or users outside the US: Vidalista 20 at $1–$2/pill on MedsBase represents 5–40× cost savings over US retail generics and 50–75× over branded Cialis. Pharmacology is identical.
• Daily-regimen users (5 mg every day, ~30 pills/month): Cost compounds here. Daily Cialis at branded US prices is $2,000+ per month; daily Vidalista 5 is roughly $25–$45 per month. For most daily users, this is the single largest cost-of-living differential available in their medication portfolio.
• Users wanting higher-than-20 mg doses: Vidalista is one of the few suppliers offering 40, 60, and 80 mg strengths. Use of these doses should be discussed with a clinician first — they are above the FDA-approved daily maximum and the response curve plateaus.
• Users with both ED and BPH: Daily tadalafil 5 mg is FDA-approved for benign prostatic hyperplasia symptoms in addition to ED — one pill, two indications. The cost-per-month differential at branded prices is substantial.

Already a Cenforce/sildenafil user wondering whether to switch molecule? Our Viagra vs Cenforce comparison covers sildenafil specifically. The headline difference between the two molecules — tadalafil’s 36-hour window vs sildenafil’s 6-hour window — is captured in our broader ED medication guide.

Pricing context: The brand-vs-generic price comparison on this page is one entry in MedsBase’s broader Brand-vs-Generic Medication Pricing Index — a quarterly-updated reference covering 15 brand-vs-generic pairs across ED, GLP-1, hair-loss, PrEP, and cosmetic clusters, with full methodology and citation disclosure.

Frequently Asked Questions

Is Vidalista literally the same drug as Cialis?

Yes. Both contain tadalafil as the active ingredient at the same labelled doses (2.5, 5, 10, 20 mg). The mechanism, onset, half-life (~17.5 hours), effective window (up to 36 hours), and side-effect profile are pharmacologically identical. The only differences are the manufacturer, the inactive excipients (fillers and dyes), and the price.

Does Vidalista really last 36 hours like Cialis?

Yes. The 17.5-hour plasma half-life is an intrinsic property of the tadalafil molecule, not of the manufacturer or formulation. A 20 mg Vidalista dose produces effective PDE5 inhibition for 24–36 hours after administration, the same as a 20 mg Cialis dose.

Is Vidalista FDA-approved?

No. Vidalista is not registered with the US FDA because it is not marketed in the United States. However, Centurion Laboratories manufactures Vidalista under WHO-GMP certification, applying the same bioequivalence and quality-control standards used by the FDA. Generic tadalafil products that ARE sold in US pharmacies (by Teva, Ascend, Lupin, and others) are FDA Orange Book AB-rated and therapeutically substitutable for Cialis.

Can I take Vidalista 5 mg daily the way some men take Cialis daily?

Yes. The 5 mg once-daily regimen FDA-approved for Cialis in 2008 applies identically to Vidalista 5 mg, because the molecule is the same. Daily dosing maintains steady-state plasma tadalafil and removes the need to time doses around sexual activity. It is also the only PDE5 dosing regimen FDA-approved for benign prostatic hyperplasia symptoms.

How is Vidalista so much cheaper than Cialis?

Three reasons. First, the branded Cialis price still carries a marketing margin recovered after the 2017 patent expiry. Second, WHO-GMP manufacturing under Indian regulatory oversight has dramatically lower production costs than Eli Lilly’s US-based manufacturing. Third, Vidalista has no direct-to-consumer advertising, no sales-rep visits, and no PBM rebate structure. The cost difference reflects marketing economics, not a difference in the molecule.

Does food affect Vidalista the way it does Viagra/Cenforce?

Minimally. Unlike sildenafil, which is meaningfully delayed by a high-fat meal, tadalafil’s absorption is essentially unaffected by food. You can take Vidalista 20 with dinner, after a heavy meal, or on an empty stomach and the onset and peak effect are largely the same. This is a property of the tadalafil molecule, not the brand.

What about the higher Vidalista strengths — 40, 60, 80 mg?

These strengths are not FDA-approved and exceed the labelled 20 mg on-demand ceiling. They exist for men who do not respond adequately to 20 mg. However, the dose-response curve for tadalafil plateaus around 20 mg — doubling the dose from 20 to 40 mg does NOT double the response, but it does roughly double the rate of side effects. If 20 mg tadalafil is not effective, the more productive next step is usually to consider a different PDE5 molecule (sildenafil, vardenafil) or to address vascular and metabolic contributors to ED, rather than dose escalation. Speak to a clinician.

Are the side effects of Vidalista the same as Cialis?

Yes. Both pills cause headache (around 14 percent), dyspepsia (around 10 percent), back or muscle pain (around 6 percent — this is the most distinctively tadalafil side effect), nasal congestion (around 4 percent), and facial flushing (around 4 percent) at typical population rates. The molecule is identical and the pharmacology is identical.

Sources

1. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. Journal of Urology. 2002;168(4 Pt 1):1332–1336.
2. US Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book), 44th edition. Tadalafil entries.
3. World Health Organization. Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. WHO Technical Report Series 1003, Annex 6, 2017.
4. Eli Lilly & Company. Form 10-K Annual Report 2017 (Cialis US patent expiration disclosure).
5. Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction. European Urology. 2006;50(2):351–359.
6. Centurion Laboratories Pvt Ltd. WHO-GMP certification under the Indian Central Drugs Standard Control Organisation; ISO 9001:2015 quality-management certification.

Last clinically reviewed: 18 May 2026.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.